Terms: = Cervical cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Treatment
23 results:
1. Using Silva pattern system to predict prognosis and plan treatment of invasive endocervical adenocarcinoma: a single-center retrospective analysis.
Li X; Pang S; Shen Y; Qu P
BMC Womens Health; 2022 Dec; 22(1):488. PubMed ID: 36460984
[TBL] [Abstract] [Full Text] [Related]
2. Perspectives on the pharmacological management of esophageal cancer: where are we now and where do we need to go?
Rogers JE; Ajani JA
Expert Opin Pharmacother; 2022 Dec; 23(17):1893-1902. PubMed ID: 36286544
[TBL] [Abstract] [Full Text] [Related]
3. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study.
He Z; Xie C; Qi X; Hu Z; He Y
BMC Womens Health; 2022 Jul; 22(1):314. PubMed ID: 35879712
[TBL] [Abstract] [Full Text] [Related]
4. Tumoral Morphologic Features From cervical Biopsies That Are Predictive of a Negligible Risk for Nodal Metastasis and Tumor Recurrence in Usual-type cervical Adenocarcinomas: A Multi-institutional Study.
Wang Y; Chang RJ; Luo RZ; Yu J; Zhang X; Yang X; Quddus MR; Li L; Yang W; Liu A; Jiang Q; Zhao R; Zhu H; Zhou F; Wang Y; Sheng X; Liu LL; Wen YL; Banet N; Sung CJ; Qi Y; Bi R; Li M; Wang Y; Li J; Lin W; Wang Y; Rivera G; Chen H; Holloway SB; Fadare O; Liu J; Wang J; Lea J; Kong B; Zheng W
Am J Surg Pathol; 2022 May; 46(5):713-724. PubMed ID: 34753864
[TBL] [Abstract] [Full Text] [Related]
5. Feasibility of intravoxel incoherent motion diffusion-weighted imaging in distinguishing adenocarcinoma originated from uterine corpus or cervix.
Zhang Q; Ouyang H; Ye F; Song Y; Xie L; Zhao X; Yu X
Abdom Radiol (NY); 2021 Feb; 46(2):732-744. PubMed ID: 32671441
[TBL] [Abstract] [Full Text] [Related]
6. Is India's public health care system prepared for cervical cancer screening?: Evaluating facility readiness from the fourth round of the District Level Household and Facility Survey (DLHS-4).
Dhillon PK; Hallowell BD; Agrawal S; Ghosh A; Yadav A; Van Dyne E; Senkomago V; Patel SA; Saraf D; Hariprasad R; Dumka N; Mehrotra R; Saraiya M
Prev Med; 2020 Sep; 138():106147. PubMed ID: 32473272
[TBL] [Abstract] [Full Text] [Related]
7. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and eac tumor bearing mice models.
Murugesan K; Koroth J; Srinivasan PP; Singh A; Mukundan S; Karki SS; Choudhary B; Gupta CM
Int J Nanomedicine; 2019; 14():5257-5270. PubMed ID: 31409988
[TBL] [Abstract] [Full Text] [Related]
8. Transforming human papillomavirus infection and the esophageal transformation zone: prime time for total excision/ablative therapy?
Rajendra S; Sharma P
Dis Esophagus; 2019 Jul; 32(7):. PubMed ID: 31304554
[TBL] [Abstract] [Full Text] [Related]
9. Study of the revisited, revised, and expanded Silva pattern system for Chinese endocervical adenocarcinoma patients.
Wang W; Song G; Lin J; Zheng X; Wang Y; Liu Y; Liu C
Hum Pathol; 2019 Feb; 84():35-43. PubMed ID: 30218754
[TBL] [Abstract] [Full Text] [Related]
10. TRAF3/cyld mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract] [Full Text] [Related]
11. Folate Receptor Alpha Expression in Platinum Resistant/Refractory Ovarian Carcinomas and Primary Endocervical Adenocarcinomas.
Rubinsak LA; Cohen C; Khanna N; Horowitz IR; Hanley KZ
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):567-572. PubMed ID: 27941566
[TBL] [Abstract] [Full Text] [Related]
12. New pattern-based personalized risk stratification system for endocervical adenocarcinoma with important clinical implications and surgical outcome.
Roma AA; Mistretta TA; Diaz De Vivar A; Park KJ; Alvarado-Cabrero I; Rasty G; Chanona-Vilchis JG; Mikami Y; Hong SR; Teramoto N; Ali-Fehmi R; Barbuto D; Rutgers JK; Silva EG
Gynecol Oncol; 2016 Apr; 141(1):36-42. PubMed ID: 27016227
[TBL] [Abstract] [Full Text] [Related]
13. Ileal Augmentation Cystoplasty Combined with Ileal Ureter Replacement After Radical treatment for cervical cancer.
Jeong IG; Han KS; Park SH; Song SH; Song G; Park HK; Choo MS; Hong B
Ann Surg Oncol; 2016 May; 23(5):1646-52. PubMed ID: 26714938
[TBL] [Abstract] [Full Text] [Related]
14. Patterns of Invasion of cervical Adenocarcinoma as Predicators of Outcome.
Roma AA
Adv Anat Pathol; 2015 Nov; 22(6):345-54. PubMed ID: 26452210
[TBL] [Abstract] [Full Text] [Related]
15. [Effect of xunxi no.1 intervention and radiotherapy on Ia-IIb stage cervical cancer with high-risk human papilloma virus infection].
Zhang PY; Liu L; Wang XB
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1066-9. PubMed ID: 21910336
[TBL] [Abstract] [Full Text] [Related]
16. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
[TBL] [Abstract] [Full Text] [Related]
17. Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Pallardy A; Bodet-Milin C; Oudoux A; Campion L; Bourbouloux E; Sagan C; Ansquer C; Testard A; Resche I; Bridji B; Kraeber-Bodéré F; Rousseau C
Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1270-8. PubMed ID: 20306032
[TBL] [Abstract] [Full Text] [Related]
18. Potential of radiosensitizing agents in cancer chemo-radiotherapy.
Girdhani S; Bhosle SM; Thulsidas SA; Kumar A; Mishra KP
J Cancer Res Ther; 2005; 1(3):129-31. PubMed ID: 17998642
[TBL] [Abstract] [Full Text] [Related]
19. Management and outcome of cervical lymph node metastases of unknown primary sites: a retrospective study.
Yalin Y; Pingzhang T; Smith GI; Ilankovan V
Br J Oral Maxillofac Surg; 2002 Dec; 40(6):484-7. PubMed ID: 12464205
[TBL] [Abstract] [Full Text] [Related]
20. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors.
Leminen A; Forss M; Lehtovirta P
Acta Obstet Gynecol Scand; 1995 Jan; 74(1):61-6. PubMed ID: 7856435
[TBL] [Abstract] [Full Text] [Related]
[Next]
